BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7686840)

  • 1. Preliminary observation on human saliva alpha-fetoprotein in patients with hepatocellular carcinoma.
    You XY; Jiang J; Yin FZ
    Chin Med J (Engl); 1993 Mar; 106(3):179-82. PubMed ID: 7686840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly sensitive sandwich enzyme immunoassay for alpha-fetoprotein in human saliva.
    Yio XY; Jiang J; Yin FZ; Ruan KH
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():519-22. PubMed ID: 1280027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
    Yap SF; Peh SC
    Malays J Pathol; 1991 Dec; 13(2):115-8. PubMed ID: 1726642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between heat shock protein 72 and alpha-fetoprotein in human hepatocellular carcinomas.
    Wang X; Zhou Y; Ying X; Guo L; Zhao Y; Fang Y
    Clin Chim Acta; 2007 Apr; 379(1-2):158-62. PubMed ID: 17250819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
    Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma.
    Taketa K; Endo Y; Sekiya C; Tanikawa K; Koji T; Taga H; Satomura S; Matsuura S; Kawai T; Hirai H
    Cancer Res; 1993 Nov; 53(22):5419-23. PubMed ID: 7693340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C.
    Bayati N; Silverman AL; Gordon SC
    Am J Gastroenterol; 1998 Dec; 93(12):2452-6. PubMed ID: 9860408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC; Chan CS; Chen GH
    Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
    Furihata T; Sawada T; Kita J; Iso Y; Kato M; Rokkaku K; Shimoda M; Kubota K
    Hepatogastroenterology; 2008; 55(86-87):1705-9. PubMed ID: 19102374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
    Mitsuhashi N; Kobayashi S; Doki T; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Takeuchi D; Suda K; Miura S; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e189-97. PubMed ID: 18466288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Decarboxyprothrombin: importance in the diagnosis of hepatocellular carcinoma].
    Bon C; Brillard B; Gelineau MC; Mailliavin A; Trépo C; Pichot J
    Ann Biol Clin (Paris); 1998; 56(2):175-81. PubMed ID: 9754243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subject diagnostic value of detecting a1pha-fetoprotein variants with a new microspincolumn method in hepatocellular carcinoma].
    Xu AF; Wang MC; Sui DM; Yuan YH; Chen G; Lou GQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):67-9. PubMed ID: 17429541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M
    Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
    Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S
    Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
    Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
    Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.